ManpowerGroup adds former Pfizer technology executive to its board

ManpowerGroup (NYSE: MAN) has elected Lidia Fonseca to its board of directors, effective November 1, 2026, according to a press release from the Milwaukee-based workforce solutions company.

Fonseca served as Executive Vice President and Chief Digital and Technology Officer at Pfizer from January 2019 to April 2026, where she led the company's enterprise AI, digital, data, and technology strategy. She also oversaw Learning & Development and Business Process Excellence during her tenure. She currently serves as Senior Advisor to Pfizer's chief executive officer and sits on the board of directors of Medtronic plc.

Prior to Pfizer, Fonseca spent a decade in diagnostics, holding the role of Senior Vice President and Chief Information Officer at Quest Diagnostics and, earlier, at LabCorp. She began her career in operations and executive leadership roles at Philips Healthcare.

Fonseca holds a bachelor's degree from the University of California, Berkeley, an MBA, and a Master of Business Informatics from Rotterdam School of Management at Erasmus University.

Jonas Prising, ManpowerGroup's Chair and CEO, said Fonseca "brings a rare combination of technology leadership, business transformation experience and a clear understanding of how AI can create value at scale."

You May Also Be Interested In

• Arcutis adds former AbbVie CMO Rob Scott to its board
• NUE Power adds former Max Power CEO to board, opens Regina office
• Orca Energy winds down UK operations, CFO to depart